What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something in-between?
How do Courts address inventiveness of a second medical use patent in light of the first medical use? Also, what issues arise with disclosure of clinical trial protocols?
Join members of Gowling WLG's global intellectual property team for a webinar to get answers to these questions and more. We will look at the validity of second medical use patents across the UK, Canada, Russia and China, and help you understand what to expect when the validity of a second medical use patent is called into question.
This program is eligible for up to 1 hour of CPD credits with the LSO and LSBC, and may be eligible for up to 1 hour of CPD/CLE credits in other jurisdictions. If you indicate that a certificate is required on your registration form, we will email you your certificate after the session.
Read the original article on GowlingWLG.com
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
